GREYPARROT/BOLLEGRAAF
Bollegraaf, the world's largest builder of recycling plants, has entered into a strategic partnership with Greyparrot, a pioneer in AI waste analytics, to transform global waste management. As part of the agreement, Bollegraaf will transfer its AI vision business to Greyparrot and also make a cash investment, for a total value of $12.8M, in Greyparrot, obtaining a non-controlling stake in the company. It will also serve as a worldwide distributor and strategic partner for Greyparrot's Analyzer, which currently provides 100% visibility into waste streams at recycling plants across 14 countries using AI camera systems.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240207738309/en/
Greyparrot Analyzer operating in the Bollegraaf Group test centre. (Photo: Business Wire)
The deal includes Greyparrot acquiring Bollegraaf’s vision-based computing intellectual property (IP) and esteemed AI development team. Greyparrot will also open its first office in mainland Europe in the Netherlands.
With this groundbreaking partnership, both companies aim to retrofit thousands of existing Materials Recovery Facilities (MRFs) and Plastics Recovery Facilities (PRFs) with advanced AI capabilities to significantly boost recycling rates and quantify material emissions. The collaboration will bring forth revolutionary smart recycling plants that are fully automated and agile, unlocking new value in waste streams while diverting millions of tonnes of waste away from landfills, oceans, and incinerators. In a development set to transform waste management, this marks a momentous acceleration in the global shift from a linear to a circular economy. Together, Greyparrot and Bollegraaf commit to developing further products that combine the strengths of both companies to make the vision of fully automated and intelligent sorting facilities a reality.
With over a 50% share in the global recycling plant market, providing turnkey recycling solutions, Bollegraaf is well-positioned to provide the physical infrastructure, while Greyparrot's proven ability to embed AI waste analytics into software and hardware systems adds the essential digital layer. In 2023 alone, Greyparrot’s Analyzer helped facilities analyse more than 25 billion waste objects, characterising them into 70+ categories in real-time to reveal seven layers of data, including material type, financial value, brand, and GHG emissions.
By 2050, the world is expected to generate 3.4 billion tonnes of waste annually. With only around 5,500 facilities handling municipal solid waste currently operating worldwide, there is a critical need to build more next-generation plants and retrofit older ones with new technologies – such as AI – to speed up processing times and improve recycling rates to meet the growing tsunami of waste.
Today, only 1% of waste is monitored in facilities, and even in advanced economies, 40% of waste sorting is done by hand. AI, and the data it unlocks in real-time, will help digitise and automate systems to capture a massive amount of lost financial value. For plastic waste in the U.S. alone, lack of visibility and automation contributes to $80B-$120B being lost a year to landfills and incineration. Greyparrot’s Analyzer gives 100% visibility into waste composition to unlock a new, more intelligent level of insight about waste that Greyparrot calls waste intelligence. With automated, real-time waste monitoring and digitised systems powered by AI, the industry can tackle the issue of 'invisible waste' and transform a traditionally labour-intensive process.
With increased data transparency, waste managers can confidently demonstrate regulatory and contractual compliance. This vital waste data on the post-consumption world will foster unprecedented collaboration across the waste value chain and those influencing it, uniting producers, waste managers and regulators to recover and reuse waste materials more sustainably.
Bollegraaf:
“With 63 years of industry experience, Bollegraaf continues to be a global leader in fully-automated innovative turnkey recycling systems. The future is clear: to further increase recycling rates we need more insight and collaboration across the value chain. We have been looking to implement AI that can power fact-based and automated decision-making to provide our clients with a much more accurate overview of their waste composition and ultimately maximise their ROI,” said Edmund Tenfelde, CEO of Bollegraaf Recycling Solutions. “We are thrilled to make this strategic investment and partner with Greyparrot to bring waste intelligence to both upcoming recycling infrastructure deployments and existing facilities worldwide. We believe that Bollegraaf's comprehensive knowledge of automation of recycling MRF operations, premium equipment quality, and unique engineering expertise empowered with Greyparrot AI systems represent the one-of-a-kind synergy that is destined for success.”
Greyparrot:
“In a world drowning in waste, a large percentage of which is recoverable, the urgency for action has never been greater. It’s time for a revolutionary leap in how we value, capture, and manage our waste. We’re excited to partner with Bollegraaf, and add to our team of experts in artificial intelligence and deep learning, to address this challenge and pave the way for the waste industry's largest rollout of AI to date,” said Mikela Druckman, CEO of Greyparrot. “Getting AI waste analytics in the hands of more plant managers, more quickly, will provide the industry the data-driven insights needed to build and operate smart MRFs that unlock new value from recovered materials and decrease the environmental impact of waste. Collaboration with plant builders and other key players is critical to making this happen, and it's a major reason why Greyparrot is hardware agnostic, making it possible to integrate our platform with all types of systems. Progress in addressing the waste crisis can only happen if we work together and commit to systemic change driven by waste intelligence.”
About Greyparrot
Greyparrot (greyparrot.ai), the leader in AI waste analytics, is applying AI to globally scale recycling and save millions of tonnes of waste from landfills and incinerators. By providing deeper, more intelligent insights about waste stream composition and value, Greyparrot is helping the waste sector recover more value from waste processing lines and reduce the environmental impact of waste.
The company’s waste intelligence platform, including Greyparrot Analyzer and Greyparrot Sync (API), reveals real-time insights on over 70 waste categories across seven layers of data, including financial value, brand, and GHG emissions, captured at multiple locations across a recycling facility. In 2023, Greyparrot analysed over 25 billion waste objects helping drive efficiency to save hundreds of thousands, to millions, of dollars per facility – while diverting millions of tonnes of waste away from landfills, oceans, and incinerators.
Using Greyparrot insights, recycling professionals, plant builders, packaging producers, and FMCG brands can make decisions to help them increase recycling efficiency, comply with recycling regulations, and improve recyclable packaging design.
Click here to see how Greyparrot’s AI waste analytics works
About Bollegraaf
The Bollegraaf Group (bollegraaf.com) is a world-leading expert and innovator in the waste sorting and recycling sector. Bollegraaf’s reputation is based on the unique quality of equipment in terms of separation performance, robustness, and ease of maintenance. A premium quality complemented by the Bollegraaf engineering expertise delivers the best solutions to the specific challenges of each customer. Through continuous and intensive investment in innovation, Bollegraaf offers state-of-the-art recycling solutions for all types of waste streams, from household waste, paper, and plastics up to construction and demolition.
Bollegraaf was founded in the Netherlands in 1961 and comprises the companies: Bollegraaf Recycling Solutions and Lubo Recycling Solutions. The company also has several subsidiaries in Europe. Van Dyk Recycling Solutions is Bollegraaf’s exclusive distributor that operates a highly successful sales office and holds a strong North American presence from its headquarters in Norwalk, U.S.
Bollegraaf’s vision is clear: There is no such thing as waste, only a pool of valuables that need to be sorted, cleaned, and prepared for re-entering a new life cycle.
Click here to see how Bollegraaf creates a world of difference with its solutions
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240207738309/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Welcomes Increased Equity Investment From L’Oréal8.12.2025 07:05:00 CET | Press release
L’Oréal to acquire an additional 10% stake in Galderma recognizing its scientific leadership in dermatology and long-term growth potential Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake from Sunshine SwissCo GmbH (a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd., acting as sellers). Following the transaction, which is subject to customary approvals, L’Oréal’s total shareholding in Galderma will rise to 20%, building on its initial investment made in August 2024. The transaction is expected to close in Q1 2026. In connection with this increased investment, Galderma will consider nominating two non-independent board candidates from L’Oréal, replacing the board members representing the consortium led by EQT, at the 2026 Annual General Meeting. Additio
Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 04:37:00 CET | Press release
The Challenge: Deepfakes undermine both the accuracy and fairness of AI face detection due to variations in human features.The Technology: Ant International’s AI model uses a novel ‘Mixture of Experts’-based Adversarial Debiasing approach to achieve superior fairness and accuracy across diverse demographics.The Impact: This advancement strengthens payment security, offering robust protection against deepfake fraud and enhancing eKYC compliance globally. Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the Nati
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
